MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0022812
Prospect Pharmaceuticals Private Limited
Prospect Pharmaceuticals Private Limited - pharma in Bishnupur, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.78 Cr
▲ 18% YoY
Net profit · FY 2024
₹15.9 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹49.12 Lakh
EBITDA margin 3.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹47 Lakh
Issued & subscribed
Open charges
₹6.39 Cr
Satisfied ₹1 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
17
Provident fund records
About Prospect Pharmaceuticals Private Limited
Data last updated:
Prospect Pharmaceuticals Private Limited is a private limited company based in Bishnupur, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2017PTC221360. Its GSTIN is 19AAJCP2314E1ZM (West Bengal).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹47 Lakh. It is led by directors Sangeeta Das and Anirban Chatterjee.
Its last annual general meeting (AGM) was held on 07 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bishnupur, West Bengal.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.78 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹15.9 Lakh (net margin 1.1%) and EBITDA of ₹49.12 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 27% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.39 Cr and satisfied charges of ₹1 Cr on record. Court records list 13 cases involving the company, including 5 filed by the company and 8 filed against it; 7 cases are pending.
Prospect Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0022812). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909WB2017PTC221360
Registration Number 221360
Incorporation Date 05 June 2017
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 07 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0022812
Key People
Sangeeta Das Director Anirban Chatterjee Director Recognitions & Rankings of Prospect Pharmaceuticals
Contact details
Prospect Pharmaceuticals Private Limited's registered office is in Bishnupur, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPremises No. 176 Mahatma Gandhi Road, Ward No. 143 P.S Haridevpur Kolkata 700104, Bishnupur, West Bengal, India – 700104
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Prospect Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Prospect Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prospect Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Prospect Pharmaceuticals Private Limited, buy the company report.
Financials of Prospect Pharmaceuticals Private Limited
FY 2025 filings availableProspect Pharmaceuticals Private Limited reported revenue of ₹14.78 Cr (up 18% YoY) for FY 2024.
Revenue · FY 2024
₹14.78 Cr ▲ 18%
Net profit · FY 2024
₹15.9 Lakh margin 1.1%
EBITDA · FY 2024
₹49.12 Lakh margin 3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 38%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 42%
5 years · compounded
▲ 26%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 18% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prospect Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prospect Pharmaceuticals Private Limited
Prospect Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeeta Das | Director | 05 Jun 2017 | 9 Years 4 Months | Current |
| Anirban Chatterjee | Director | 05 Jun 2017 | 9 Years 4 Months | Current |
Auditor
Prospect Pharmaceuticals Private Limited is audited by Shankar Singh & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shankar Singh & Associates | FY 2023 | 326453E |
Shareholding
The shareholding of Prospect Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prospect Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.39 Cr
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Dec 2024 | 101014620 | Others | ₹2.81 Cr | Open | |
| 13 Nov 2024 | 101016489 | Others | ₹1.33 Cr | Open | |
| 03 Dec 2022 | 100646768 | Bank of India | ₹2.25 Cr | Open | |
| 15 Feb 2018 | 100162013 | Indian Bank | ₹1 Cr | Satisfied |
To see the full charge records of Prospect Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Prospect Pharmaceuticals Private Limited has 13 court cases on record: 5 filed by Prospect Pharmaceuticals, 8 filed against it. 7 cases are pending and 6 are disposed.
Total cases
13
Filed by the company
5
Filed against the company
8
Pending
7
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 4 | 2 |
| District courts | 5 | 4 | 5 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Bajaj Housing Finance Ltd | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Bajaj Housing Finance Limited Through Prabhjyot Singh Wasrikar | Pending |
| Bombay High Court | Court case (CARBP) | Filed against the company by Iifl Finance Limited | Disposed |
| Calcutta High Court | Arbitration matter | Filed by the company against Shriram Asset Reconstruction Private Limited | Disposed |
| Calcutta High Court | Court case (AP-COM) | Filed against the company by Bajaj Housing Finance Limited | Disposed |
To see the full case history of Prospect Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prospect Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Prospect Pharmaceuticals Private Limited has a workforce of 17 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
17
Active EPFO establishments
1
Employee growth
6.25%
GST
Prospect Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAJCP2314E1ZM | West Bengal | Active | 14 Feb 2018 |
To see the full GST registrations and return filing status of Prospect Pharmaceuticals Private Limited, buy the company report.
Recent activity
Prospect Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Abubakkar Gazi ceased to be Director on 07 Apr 2021.
AGM
Prospect Pharmaceuticals Private Limited last Annual general meeting of members was held on 07 Oct 2025 as per latest MCA records.
Filing
Prospect Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Others amounted to Rs. 2.81 Cr with Charge ID 101014620 was registered on 05 Dec 2024.
Charges
A charge with Others amounted to Rs. 1.33 Cr with Charge ID 101016489 was registered on 13 Nov 2024.
Charges
A charge with Bank Of India of Rs. 2.25 Cr registered on 03 Dec 2022 with Charge ID 100646768 was modified on 28 Jun 2023.
Charges
A charge with Bank Of India amounted to Rs. 2.25 Cr with Charge ID 100646768 was registered on 03 Dec 2022.
Charges
A charge registered on 15 Feb 2018 via Charge ID 100162013 with Indian Bank was fully satisfied on 19 Nov 2022.
Charges
A charge with Indian Bank of Rs. 1.00 Cr registered on 15 Feb 2018 with Charge ID 100162013 was modified on 01 Aug 2022.
Ceased
Abubakkar Gazi ceased to be Director.
Charges
A charge with Indian Bank amounted to Rs. 1.00 Cr with Charge ID 100162013 was registered on 15 Feb 2018.
Appointed
Anirban Chatterjee was appointed as Director.
Appointed
Sangeeta Das was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Prospect Pharmaceuticals is an active private limited company based in Bishnupur, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 June 2017 (9+ years old) and is registered under CIN U51909WB2017PTC221360.
Prospect Pharmaceuticals has 2 current directors:
- Sangeeta Das - Director
- Anirban Chatterjee - Director
The latest financial statements of Prospect Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 07 October 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Prospect Pharmaceuticals is 19AAJCP2314E1ZM, registered in West Bengal.
The CIN (Corporate Identification Number) of Prospect Pharmaceuticals is U51909WB2017PTC221360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prospect Pharmaceuticals has 13 court cases on record: 5 filed by the company and 8 filed against it. 7 are pending. Most are in the high courts.
Prospect Pharmaceuticals was incorporated on 05 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.
Abubakkar Gazi ceased to be Director on 07 Apr 2021. Anirban Chatterjee was appointed as Director on 05 Jun 2017. Sangeeta Das was appointed as Director on 05 Jun 2017.
Yes, Prospect Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0022812).
The registered office of Prospect Pharmaceuticals is at Premises No. 176 Mahatma Gandhi Road, Ward No. 143 P.S Haridevpur Kolkata 700104, Bishnupur, West Bengal, India – 700104.